Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps

M Block - Expert opinion on drug metabolism & toxicology, 2015 - Taylor & Francis
Introduction: Modeling and simulation have become important means of answering
questions relevant to the development of a drug, making it possible to assess risks early and …
被引用次数：19 相关文章

Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.

M Block - Expert Opinion on Drug Metabolism & Toxicology, 2015 - europepmc.org
Modeling and simulation have become important means of answering questions relevant to
the development of a drug, making it possible to assess risks early and to reduce costs …

Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps

M Block - Expert opinion on drug metabolism & toxicology, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Modeling and simulation have become important means of answering
questions relevant to the development of a drug, making it possible to assess risks early and …

Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps

M Block - Expert Opinion on Drug Metabolism & Toxicology, 2015 - hero.epa.gov
Introduction: Modeling and simulation have become important means of answering
questions relevant to the development of a drug, making it possible to assess risks early and …